White Paper:
Autologous Amniotic Fluid: The Next Era of Cesarean Wound Care
Explore how autologous amniotic fluid may support healing and improve outcomes following cesarean delivery.
A Major Step Forward for Cesarean Wound Care
Cesarean deliveries are common but not without risk.
Emerging research points to autologous amniotic fluid (AAF) as a promising approach for improving wound-healing outcomes.
This white paper explores findings around the future of cesarean wound care, including:
- Key challenges impacting cesarean wound healing outcomes
- The clinical properties of amniotic fluid in surgical applications
- Why autologous use (patient-derived) matters
- Key insights from Duke University research
Download the White Paper
Backed by Clinical Research
In the white paper, you will uncover key takeaways about autologous amniotic fluid in cesarean wound care from a study facilitated by Duke University Department of Obstetrics and Gynecology.
Efficiency and Practicality
See how the collection of autologous amniotic fluid fits into standard cesarean procedure
Safety Profile
Explore how the use of AAF compares to standard rates of SSIs, wound complications, and other adverse events
Wound Healing and Cosmesis Outcomes
Find out how autologous amniotic fluid relates to wound healing and scarring following a cesarean delivery
The New Era of Cesarean Wound Care Starts Here
Download the white paper to explore the clinical potential of autologous amniotic fluid.